Isbn: 9780309120883 - breakthrough business models: drug development for rare and neglected diseases and individualized therapies: workshop summary (clinical trial data sharing) (11 Ergebnisse)

Zustand: good. A copy that has been read, remains in good condition. All pages are intact, and the cover is intact. The spine and cover show signs of wear. Pages can include notes and highlighting and show signs of wear, and the copy can include "From the library of" labels or previous owner inscriptions. 100% GUARANTEE! Shipped with delivery confirmation, if you're not satisfied with purchase please return item! Ships via media mail.…

Zustand: As New. Unread book in perfect condition.

Zustand: New.

Paperback. Zustand: new. Paperback. The process for developing new drug and biologic products is extraordinarily expensive and time-consuming. Although large pharmaceutical companies may be able to afford the cost of development because they can expect a large return on investment, organizations developing drugs to treat rare and neglected diseases are unable to rely on such returns. On June 23, 2008, the Institute of Medicine's Forum on Drug Discovery, Development, and Translation held a public workshop, "Breakthrough Business Models: Drug Development for Rare and Neglected Diseases and Individualized Therapies," which sought to explore new and innovative strategies for developing drugs for rare and neglected diseases. The process for developing new drug and biologic products is extraordinarily expensive and time-consuming. Although large pharmaceutical companies may be able to afford the cost of development because they can expect a large return on investment, organizations developing drugs to treat rare and neglected diseases are unable to rely on such returns. On June 23, 2008, the Institute of Medicine's Forum on Drug Discovery, Development, and Translation held a public workshop, "Breakthrough Business Models: Drug Development for Rare and Neglected Diseases and Individualized Therapies," which sought to explore new and innovative strategies for developing drugs for rare and neglected diseases. Shipping may be from multiple locations in the US or from the UK, depending on stock availability.…

Zustand: New. Num Pages: 150 pages. Category: (P) Professional & Vocational. Dimension: 229 x 152 x 10. Weight in Grams: 249. . 2009. New. paperback. . . . .

Zustand: As New. Unread book in perfect condition.

Paperback. Zustand: Brand New. 150 pages. 8.80x6.00x0.40 inches. In Stock.

Zustand: New.

Zustand: New. Num Pages: 150 pages. Category: (P) Professional & Vocational. Dimension: 229 x 152 x 10. Weight in Grams: 249. . 2009. New. paperback. . . . . Books ship from the US and Ireland.

Zustand: New.

Paperback. Zustand: new. Paperback. The process for developing new drug and biologic products is extraordinarily expensive and time-consuming. Although large pharmaceutical companies may be able to afford the cost of development because they can expect a large return on investment, organizations developing drugs to treat rare and neglected diseases are unable to rely on such returns. On June 23, 2008, the Institute of Medicine's Forum on Drug Discovery, Development, and Translation held a public workshop, "Breakthrough Business Models: Drug Development for Rare and Neglected Diseases and Individualized Therapies," which sought to explore new and innovative strategies for developing drugs for rare and neglected diseases. The process for developing new drug and biologic products is extraordinarily expensive and time-consuming. Although large pharmaceutical companies may be able to afford the cost of development because they can expect a large return on investment, organizations developing drugs to treat rare and neglected diseases are unable to rely on such returns. On June 23, 2008, the Institute of Medicine's Forum on Drug Discovery, Development, and Translation held a public workshop, "Breakthrough Business Models: Drug Development for Rare and Neglected Diseases and Individualized Therapies," which sought to explore new and innovative strategies for developing drugs for rare and neglected diseases. Shipping may be from our Sydney, NSW warehouse or from our UK or US warehouse, depending on stock availability.…